IP Verse

Galderma competitive analysis

Latest publications and patents of Galderma New

Explore the latest publications and patents granted to Galderma, showcasing their recent innovations and technological advancements.

Last updated on: Sep 27, 2025

Publication Number	Publication Date	Title	Legal Status
Get instant update for new patents of Galderma
EP2854803	Aug 24, 2022	Topical Compositions In The Form Of A Gel Containing A Particular Solubilised Retinoid	Patent Maintained As Amended
EP2854802	Aug 24, 2022	Oil/Water-Emulsion-Type Topical Compositions Containing A Retinoid	Patent Maintained As Amended
EP1861083	Jan 31, 2018	Composition Based On An Avermectin And Azelaic Acid In Particular For Treating Rosacea	No Opposition Filed Within Time Limit

Latest oppositions filed by Galderma

Explore patent oppositions filed by Galderma against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 2, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3079714	Long Lasting Effect Of New Botulinum Toxin Formulations	MEDY TOX	Aug 24, 2021
EP2674147	Hyaluronic Acid-Based Gels Including Anesthetic Agents	ALLERGAN INDUSTRIE	Sep 30, 2020

Latest patents of Galderma opposed by its competitors

Explore Galderma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025

Patent Number	Grant Date	Title	Total Oppositions
EP2854802	Aug 24, 2022	Oil/Water-Emulsion-Type Topical Compositions Containing A Retinoid	1
EP2854803	Aug 24, 2022	Topical Compositions In The Form Of A Gel Containing A Particular Solubilised Retinoid	1

Latest PTAB cases involving Galderma

Discover the latest PTAB cases involving Galderma, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 3, 2025

Proceeding Number	Filing Date	Petitioner	Respondent	Status
Get alerts for PTAB Cases involving Galderma
PGR2019-00062	Sep 4, 2019	GALDERMA	MEDY TOX	Final Written Decision
IPR2015-01782	Aug 20, 2015	DR REDDYS LABORATORIES	GALDERMA LABORATORIES	Institution Denied
IPR2015-01778	Aug 20, 2015	DR REDDYS LABORATORIES	GALDERMA LABORATORIES	Institution Denied
IPR2015-01777	Aug 20, 2015	DR REDDYS LABORATORIES	GALDERMA LABORATORIES	Institution Denied
IPR2015-01119	Apr 29, 2015	GALDERMA	ALLERGAN	Terminated
IPR2014-01422	Aug 29, 2014	GALDERMA	ALLERGAN USA	Institution Denied
IPR2014-01417	Aug 29, 2014	GALDERMA	ALLERGAN INDUSTRIE	Institution Denied

Peer Comparison New

IP litigation analysis comparing Galderma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced	Strategy Type
GALDERMA RESEARCH	-	2	-	-	Non-Active
GENERICS UK	212	-	-	-	Highly Aggressive